Literature DB >> 7727887

Severe hyponatremia and hyperkalemia induced by trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia.

H Noto1, Y Kaneko, T Takano, K Kurokawa.   

Abstract

An antimicrobial agent trimethoprim-sulfamethoxazole (Tmp-Smx) does not usually cause electrolyte disturbances at regular doses, and few cases of Tmp-Smx-induced electrolyte imbalance have been reported in the English-language literature to date. Recently, however, we treated two patients with Pneumocystis carinii pneumonia who developed severe hyponatremia and hyperkalemia on administration of high-dose Tmp-Smx. These electrolyte disturbances were attributable to the direct effect of Tmp-Smx on the renal distal tubules, were reversible, and corrected by infusion of a sodium-enriched and potassium-free liquid. Therefore, it is suggested that even after electrolyte disturbances have occurred, high-dose Tmp-Smx therapy may be continued for severe infectious diseases under appropriate electrolyte correction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7727887     DOI: 10.2169/internalmedicine.34.96

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

Review 1.  Analysis of the Clinical Characteristics of Hyponatremia Induced by Trimethoprim/Sulfamethoxazole.

Authors:  Haibo Lei; Xiang Liu; Jiang Zeng; Zhiqiang Fan; Yang He; Zuojun Li; Chunjiang Wang
Journal:  Pharmacology       Date:  2022-04-05       Impact factor: 3.429

2.  Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial.

Authors:  Todd C Lee; Emily G McDonald; Zahra N Sohani; Guillaume Butler-Laporte; Andrew Aw; Sara Belga; Andrea Benedetti; Alex Carignan; Matthew P Cheng; Bryan Coburn; Cecilia T Costiniuk; Nicole Ezer; Dan Gregson; Andrew Johnson; Kosar Khwaja; Alexander Lawandi; Victor Leung; Sylvain Lother; Derek MacFadden; Michaeline McGuinty; Leighanne Parkes; Salman Qureshi; Valerie Roy; Barret Rush; Ilan Schwartz; Miranda So; Ranjani Somayaji; Darrell Tan; Emilie Trinh
Journal:  BMJ Open       Date:  2022-07-21       Impact factor: 3.006

3.  Trimethoprim-sulfamethoxazole-induced hyperkalemia in a patient with normal renal function.

Authors:  L Connor Nickels; Christine Jones; Latha Ganti Stead
Journal:  Case Rep Emerg Med       Date:  2012-12-13

4.  Hypovolemic hyponatremia after trimethoprim use.

Authors:  V Chaitanya; B S Lakshmi; B O Goud; R Ram; B Vengamma; V S Kumar
Journal:  Indian J Nephrol       Date:  2015 Nov-Dec

5.  A case of extreme hyponatremia without neurologic symptoms.

Authors:  Na Zhou; Chang Yang
Journal:  Clin Case Rep       Date:  2019-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.